White House releases drug policy priorities
The Biden-Harris administration yesterday sent Congress its first-year drug policy priorities, as required by each new administration.
They call for expanding access to evidence-based treatment; advancing racial equity in drug policy; enhancing evidence-based efforts to reduce harm; supporting evidence-based efforts to prevent youth substance use; reducing the supply of illicit substances; removing barriers to employment for people in recovery and expanding the addiction workforce; and expanding access to recovery support services.
Related News Articles
Headline
The White House Feb. 1 announced it placed tariffs on imported goods from Canada, Mexico and China. The tariffs for Mexico and Canada have since been delayed…
Headline
The AHA Jan. 28 voiced support for bipartisan legislation to reauthorize for five years the Dr. Lorna Breen Health Care Provider Protection Act, which provides…
Chairperson's File
There is so much for health care leaders to navigate when it comes to public policy and government relations. Thankfully, the AHA has an expert team with…
Headline
Sens. Dick Durbin, D-Ill., and Chuck Grassley, R-Iowa, Jan. 23 introduced the Drug-price Transparency for Consumers Act, legislation supported by the AHA that…
Perspective
All eyes this week have been on Washington, D.C., as President Trump was inaugurated and the 119th Congress — with Republicans holding majorities in the House…
Headline
The AHA yesterday released its 2025 Advocacy Agenda that details the association's key priorities for Congress, the Administration, regulatory agencies and…